# US 2020/0392137 A1 · Toll-like receptor 7 (tlr7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0392137 A1
- Document ID: US20200392137A1
- Status: Published application
- Kind: A1
- Application number: 17/003,385
- Filed: 2020-08-26
- Published: 2020-12-17
- Earliest claimed: 2017-08-16
- Assignees: Bristol-Myers Squibb Company
- Applicants: Bristol-Myers Squibb Company
- Inventors: Liqi HE; Sanjeev Gangwar; Yam B. Poudel; Prasanna Sivaprakasam
- Web page: https://patentgrep.com/patent/US20200392137A1

## CPC

- C07D 473/18: one oxygen and one nitrogen atom, e.g. guanine
- A61P 37/04: Immunostimulants
- A61K 47/6841: {the antibody targeting a RNA virus}
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Compounds having a structure according to formula (I) or (II) where R1, R2, R3, R4, Ar and X1 are as defined herein, are agonists for the Toll-like receptor 7 (TLR7) and can be used as adjuvants for stimulating the immune system. Some such compounds can be used in conjugates for targeted delivery to the organ or tissue of intended action.

## Claims

### Claim 1

A compound having a structure according to formula (Ib-16):
